Want to see IN:BLUEJET full AI Analyst Report?
Blue Jet Healthcare Limited (BLUEJET) Price & Analysis
BLUEJET Stock Chart & Stats
- Day’s Range
- INR 496.65 - INR 510.10
- 52-Week Range
- INR 325.20 - INR 688.00
- Previous Close
- INR 503.85
- Volume
- 75.53K
- Average Volume (3M)
- 27.87K
- Market Cap
- INR 95.47B
- Enterprise Value
- INR 53.45B
- Total Cash (Recent Filing)
- INR 3.23B
- Total Debt (Recent Filing)
- INR 0
- Price to Earnings (P/E)
- 37.2
- Beta
- 1.50
- Next Earnings
- Nov 05, 2026
- EPS Estimate
- 4.4
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 0.24%
Bulls Say, Bears Say
Bulls Say
Strong And Sustained Profitability
Consistently high gross and net margins indicate that Blue Jet has maintained meaningful economics across multiple years. This profitability can support reinvestment, absorb some cost pressure, and provide a stronger foundation for growth than a low-margin API business.
Exceptionally Conservative Balance Sheet
Extremely low leverage reduces financial risk and interest-related pressure, giving Blue Jet substantial flexibility through weaker operating periods. A conservative balance sheet also preserves capacity to fund working capital, investments, or expansion without relying heavily on additional borrowing.
Efficient Use Of Shareholder Capital
Strong reported returns on equity suggest the company has generated attractive earnings relative to its shareholder capital while continuing to build its equity base. This combination supports the view that the business has historically used capital efficiently, despite recent growth volatility.
Bears Say
Material FY2026 Revenue Contraction
The sharp FY2026 revenue decline interrupts the company’s earlier expansion and reduces visibility into demand and operating scale. If weaker sales persist, fixed-cost absorption, customer ordering patterns, and the ability to sustain historical profitability could all come under pressure.
Inconsistent Cash Conversion
Uneven conversion of reported earnings into cash weakens confidence in the quality and repeatability of profits. Weak operating cash flow relative to earnings and inconsistent free cash flow may constrain internally funded investment and signal recurring working-capital or timing pressures.
Recent Margin Compression And Weaker Momentum
Margin compression after strong prior-year performance suggests that the recent revenue slowdown is affecting operating quality, not just the top line. A less favorable mix or weaker utilization could make it harder to preserve historical margins if subdued growth continues over coming quarters.
Blue Jet Healthcare Limited News
BLUEJET FAQ
What was Blue Jet Healthcare Limited’s price range in the past 12 months?
What is Blue Jet Healthcare Limited’s market cap?
When is Blue Jet Healthcare Limited’s upcoming earnings report date?
How were Blue Jet Healthcare Limited’s earnings last quarter?
Is Blue Jet Healthcare Limited overvalued?
Does Blue Jet Healthcare Limited pay dividends?
What is Blue Jet Healthcare Limited’s EPS estimate?
How many shares outstanding does Blue Jet Healthcare Limited have?
What happened to Blue Jet Healthcare Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Blue Jet Healthcare Limited?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Blue Jet Healthcare Limited
Blue Jet Healthcare Ltd. is a company that focuses on the manufacturing and supply of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), which are critical components for the pharmaceutical and healthcare sectors. Its product offerings include integrated intermediates used in contrast media, saccharin and its associated salts, and a range of specialized pharmaceutical intermediates and APIs. The company also delivers comprehensive contract development and manufacturing (CDMO/CMO) and development services. Founded in 1968, Blue Jet Healthcare is headquartered in Thane, India, and maintains a broad international operational footprint across countries such as India, Norway, the United States, Sweden, Italy, and Spain.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Shiven Arora
- Employees
- 581
- Website
- www.bluejethealthcare.com
- Address
- Bhumiraj Costarica, Plot No. 1 & 2, Thane, MA, 400705, IN
Blue Jet Healthcare Limited (BLUEJET) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 6 | 10 |
| Technical Analysis | 1 | 6 | 3 |
| Moving Averages | 5 | 0 | 7 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| IN:BIOCONBiocon Limited | ||
| IN:CONCORDBIOConcord Biotech Ltd. | ||
| IN:DCALDishman Carbogen Amcis Ltd. | ||
| IN:SYNGENESyngene International Ltd. | ||
| IN:ONESOURCEOneSource Specialty Pharma Limited |







